Introduction
T lymphocytes are a unique type of blood cells, as they require the thymus as a dedicated organ for their development. Although T cell development has been described outside the thymus (1-3), it is the thymic microenvironment that primarily supports early T cell development and guides the process of thymocyte positive and negative selection.
Thymopoiesis relies on a constant influx of hematopoietic stem cell (HSC)-derived progenitors from the bone marrow (BM). It is generally agreed that BM-resident HSC (defined as Lin -Thy1.1 lo Sca-1 + c-Kit + Flt3 -) give rise to multipotent progenitors (MPPs) that distinct developmental pathway for NK cells in the thymus that could share properties with T cell development (25) . Along these lines, a recent report demonstrated some T cell potential in the previously described population of BM-resident NK cell precursors (26, 27) .
The existence of an evolutionarily conserved bi-potent T/NK progenitor in the thymus demonstrates that the thymic microenvironment is permissive for and can selectively foster the development of T lymphocytes and thymic NK cells. Lineage choice depends on two crucial mechanisms: the initiation of a developmental program for a certain lineage ("specification") and the final exclusion of any other fate ("commitment"). These processes involve a cascade of irreversible checkpoints that are required to shape the identity of the resultant lymphoid cell subset. Changes in gene expression, developmental potential and proliferation levels mark these phases, and this process is well described in the thymus.
During the initial stages of development, T cell progenitors lack expression of CD4 and CD8 co-receptors and are therefore termed 'double negative (DN)'. DN thymocytes differentially express CD44 and CD25 surface makers (28) . ETP have the CD44 + CD25phenotype (DN1 stage) and acquire CD25 as they mature to become CD44 + CD25 + DN2 cells. Both of these early thymocyte precursor stages show high levels of proliferation that are driven by external signals derived from growth factors, including stem cell factor and interleukin (IL)-7.
Efficient T cell progenitors are found among DN1 cells bearing the corresponding receptor (c-Kit + ); this fraction is a very minor population (0.01%) of the young adult mouse thymus (17, 29) . The DN2 population is further enriched with efficient T cell progenitors (30) and can be subdivided into a c-Kit high DN2a population that maintains a potential to develop into DCs, mast cells, monocytes and NK cells (15, (31) (32) (33) , while the c-Kit low DN2b population has extinguished non T-cell potentials (34) . Early thymocytes that reach the DN3 stage have down-regulated CD44 expression and are fully committed to the T cell lineage. While TCRβ D-J rearrangements may start before this stage (35) , DN3 cells arrest their growth to allow for efficient TCR rearrangement. Successful in-frame TCRβ rearrangements lead to expression of a functional pre-TCR, composed of the invariant pre-Tα chain, the TCRβ chain and the associated CD3 complex. Signals from the pre-TCR (β-selection) drive further thymocyte differentiation to the double-positive stage (36) .
The cell surface phenotype of the aforementioned bi-potent T/NK progenitor (NK1.1 + CD117 + CD44 + CD25 + ) strongly suggested that this population was contained amongst the DN2 subset of early thymocytes (30) . DN2 cells uniformly express IL-7Rα (37) and a subset of the bi-potent T/NK precursors express IL-2Rβ (30) . It is not clear whether IL-2Rβ expression varies amongst DN2a versus DN2b thymocyte subsets (38) or whether the T, NK or bi-potent T/NK potential of cells bearing IL-2Rβ differs from those lacking this cytokine receptor chain.
To acquire a T cell identity, thymocyte progenitors must first switch off other cell fates. The early stages of thymocyte development are marked by dramatic changes in gene expression and include key regulators of lymphocyte development. The complex interplay between external signals (cell-cell interactions, soluble factors of the microenvironment) and intrinsic signals (via transcription factors) determines lineage choice. The thymus creates a unique environment that strongly supports T cell development, but is also permissive for development of other cell types. In this review, we will consider some of the extrinsic and intrinsic regulators that condition the choice between T cell and NK cell development in the thymus from T/NK bi-potent precursors.
Regulators of the T and NK cell fate determination in the thymus

Interleukin-7
Interleukin-7 (IL-7) is an essential cytokine for T cell development in both mice and man (39, 40) . IL-7 is produced by epithelial stromal cells in the thymus and bone marrow (41, 42) and by fibroblastic reticular cells in the lymph node (43) . IL-7 signals through the heterodimeric IL-7 receptor (IL-7R) composed of the IL-7Rα chain associated with the common cytokine receptor gamma chain (γ c ) (reviewed in (44) . The IL-7R is expressed by early lymphoid precursors (including CLP, pro-B, pro-T and most naïve mature T cells) and therefore plays a critical role in the homeostasis of developing as well as mature T lymphocytes. IL-7 signaling impacts via several biochemical pathways.
Activation of Janus kinases (JAK)-1 and -3 lead to subsequent phosphorylation and dimerization of signal transducer and activator of transcription 5 (STAT5) members that control gene expression. Parallel stimulation of phosphoinoside-3 kinases (PI3Ks) as well as Ras and mitogen-activated protein kinase (MAPK) pathways also impinge on gene transcription and survival (reviewed in (45) .
Loss of IL-7 function in mice leads to a strong decrease in thymic cellularity, although TCRαβ cells (but not TCRγδ cells) are produced and enter the peripheral lymphoid tissues (46, 47) . Interestingly, IL-7 or IL-7R-deficient mice show a relative increase of DN1 T cell precursors (39, 46) , suggesting that homeostasis of post-DN1 thymocytes depend on IL-7 signals that mediate both survival and proliferative effects (40, 48, 49) . IL-7Rα is clearly expressed during the DN1 and DN2 stage of T cell development, but is sharply downregulated when cells progress to the DN3 stage (37) . This expression pattern is consistent with a model whereby IL-7-driven DN1/DN2 proliferation generates the cellular substrate for TCR rearrangements that take place at the non-proliferating DN3 stage. This state of IL-7 nonresponsiveness persists at the double positive stage but then IL-7 re-emerges as an important factor during the cell-fate decision at the later CD4 or CD8 single positive stage, as signals through IL-7Rα have been proposed to promote CD8 T cell differentiation (50) (51) (52) . Finally, IL-7 maintains naïve T cells in the periphery and can contribute to 'homeostatic' expansion and proliferation of peripheral T cells following insults that cause lymphopenia (53) , reviewed in (54) .
BM NK cell development proceeds normally in the absence of IL-7 (55) and numbers and function of peripheral NK cell numbers in IL-7-deficient mice are unperturbed (46) . In contrast, NK cells in the thymus appear highly dependent on IL-7 and this is correlated with a predominant expression of IL-7Rα on this subset of NK cells (56) . As such, thymic NK cells, but not BM-derived NK cells, resemble T cells in their homeostatic requirement for IL-7.
Additional similarities between thymic NK cells and T cells include their developmental requirement for GATA-3 (see below).
Considering their IL-7 dependency, one would predict that DN2 (and to a lesser extent DN1 cells) as well as thymic NK cells would localize in proximity to IL-7 producing thymic stromal cells. Using an IL-7 reporter mouse, IL-7-expressing MHC class II + thymic epithelial cells (TECs) could be identified (57) . The majority of these IL-7 + TECs expressed cortical markers and were localized as a band of cells at the cortico-medullary junction (CMJ). Petrie and Zúñiga-Pflücker reviewed the distinct microenvironments in the thymus, correlating the location of different thymocyte populations throughout development (58) . ETPs enter the thymus at the CMJ, where DN1 and DN2 cells proliferate before migrating through the cortex. When T cell commitment is completed at the DN3 stage, the thymocytes are found in the sub-capsular zone where IL-7 expression is lowest. Although ETPs do not yet express IL-7Rα, its expression is increased as cells progress to the DN2 stage and gradually decreases as cells progress further during development. Interestingly, thymic NK cells have been found primarily at the CMJ (J. Di Santo, unpublished observations). Taken together, these findings suggest that IL-7 availability conditions not only early thymocyte survival and proliferation but also plays a role in development and/or maintenance of NK cells within the thymus.
Interleukin-15
Interleukin-15 (IL-15) was first discovered as an IL-2-like cytokine that promoted T cell activation in vitro (59, 60) . The molecular basis underlying the biological similarities between IL-2 and IL-15 can be explained by fact that the receptors for these cytokines share multiple components including the IL-2Rβ and γ c chains (44, 61) . Nevertheless, these structurally related cytokines have unique biological roles in vivo in part due to the expression and function of their corresponding IL-2Rα and IL-15Rα chains (62, 63) . Studies using mice deficient for IL-2Rα and IL-2Rβ suggested that IL-2 is required for regulation of peripheral T lymphocyte activation (via regulatory T cells), whereas IL-15 is a critically required for development and survival of NK cells (64, 65) , as well as other innate T lymphocytes (reviewed in (66)).
The essential role for IL-15 in BM NK cell development begins with the triggering of IL-2Rβ chains expressed by NK cell progenitors (NKP) (26) . NKP are Linprogenitors that lack most cell surface receptors expressed by peripheral NK cells (including NK1.1 and DX5) and upon IL-15 stimulation, proliferate and differentiate to generate phenotypically mature, and fully functional NK cells. IL-15 is therefore important for the development and maintenance of immature and mature NK cells, but not for the generation of NKPs (55) . This last point is important as it indicates that other non-γ c -dependent signals control NK cell lineage commitment. IL-15 also plays an essential role in the development of thymic NK cells (56, 67) . As thymic NK cell development also requires IL-7 (56), unique and/or redundant roles for IL-7
and IL-15 in the development, differentiation and maintenance of this unusual NK cell subset can be envisaged. The observation that both IL-7 and IL-15 are essential for NK thymopoiesis, indicates that these signals delivered by these cytokines can not compensate for each other. Both IL-7 and IL-15 can promote cell survival by enhancing expression of antiapoptotic members of the Bcl2 family (48, 65) . Perhaps thymic NK cells receive limiting survival signals from each of these two cytokines and survival can only be ensured if both cytokines are present. An alternative explanation is that IL-7 and IL-15 act at distinct but sequential stages in thymic NK cell development. One probable scenario would include an important role for IL-7 in the development and/or maintenance of ETPs or T/NK bi-potent cells (that contain NK cell precursors), while IL-15 would act in a fashion similar to that of BM NK cell development, promoting survival, proliferation and differentiation of committed NKP once they have been fully specified. It is interesting to recall that before concluding the identification of the bi-potent T/NK progenitor, it was shown that cytokines influenced cell fate decisions in this precursor population with the levels of IL-2 and IL-15 controlling whether IL-2Rβ + TCRcells develop into T or NK cells (62) . As such, intrathymic IL-15 availability would dominantly promote (and control) thymic NK cell development, but might not impact on the initial T versus NK cell fate decision at the level of the T/NK bi-potent progenitor. This notion is also consistent with the lack of any obvious defects in early thymopoiesis in IL-15-deficient mice.
Notch1
Notch1 is a transmembrane signaling receptor required at multiple stages of T cell development. Notch1 signaling is essential for the initiation of T cell development in the thymus, as Notch1-deficiency completely ablates further T cell development from thymic ETPs (68, 69) . Furthermore, Notch1 is critical for suppression of B cell fate from thymic progenitors as Notch1 deficiency leads to thymic B cell development. Ectopic activation of Notch1 signaling in hematopoietic progenitors resulted in emergence of T lymphocyte development at the expense of B cell development in the bone marrow that was independent of the thymic microenvironment (70) . Furthermore, Notch1 signaling influences later stages of T cell development, including the αβ versus γδ T cell fate (71) , the choice between CD4 and CD8 T cell fate (72) , as well as the choice between Th1 versus Th2 cell fates (73) .
In mammals, Notch signaling is activated by binding to one of four known ligands: Jagged1 (74), Jagged2 (75), Delta-like-1 (Dll1) or Delta-like-4 (Dll4) (76, 77) . Ligand binding leads to a series of proteolytic cleavages of the Notch molecule, resulting in the membrane release and transport of the intracellular Notch domain to the nucleus where it behaves as a transcriptional activator (reviewed in (78)). While in vitro studies indicated that both Dll1 and Dll4 promoted Notch1-dependent T cell development (79) , thymic epithelial cells (TECs) only express Dll4 (80, 81) . Furthermore, inactivation of Dll4 expression in TECs leads to a complete block in T cell development (82) indicating that Dll4 is the essential Notch1 ligand provided by the thymic microenvironment that is required for initiation of T cell development. This strengthens the view that the thymus creates a special niche that provides Notch ligands, guiding hematopoietic progenitors towards the initiation of the T cell showed that Notch signals are required for the generation of ETPs, while the population of phenotypically identical Lin -Sca-1 + c-Kit + cells in the BM and in the circulation was not affected (83) . Notch1 deletion in HSC does not significantly impact on subsequent BM NK cell development or on the overall numbers, phenotype or function of splenic NK cells (84) .
Recently, the effect of Notch1 deletion on thymic NK cell development was investigated (Ribiero et al, submitted). While Notch1-deficiency completed abrogated ETP and subsequent T cell development as expected (68) (69) (70) , the number of thymic NK cells that developed in the absence of Notch1 was normal. Collectively, these results indicate that Notch1 signals neither inhibit nor promote NK cell development in the thymus.
GATA-3
GATA-3 is a zinc finger transcription factor recognizing a consensus WGATAR motive that is involved in multiple types of tissue development (85, 86) . Germ-line GATA-3deficiency leads to lethality by embryonic day 11.5 (87) . In the hematopoietic system, GATA-3 plays critical roles in the development of T and thymic NK cells as GATA-3deficient hematopoietic progenitors fail to generate these cells. Concerning T cell development, few cells progress past the DN2 stage (82, 88, 89) , and using conditional gene ablation techniques, GATA-3 was also shown to be required at later stages of T cell development, including β-selection (90), the generation of CD4 + SP thymocytes (90) and for CD4 + T-helper-2 cell (T H 2) differentiation (91, 92) . GATA-3 dependency correlates with expression levels that are highest in DN2 and DN3, diminish in DP and rises again during generation of CD4 SPs and T H 2 cells (88).
Although GATA-3 is essential for T cell development, overexpression of GATA-3 in T cell progenitors completely blocks T cell development and diverts their development towards the mast cell lineage (93) . In this case, Notch acts as an antagonist of GATA-3 instead of as a collaborator in T cell development, demonstrating that transcription factors can have multiple effects, based on tightly regulated expression levels. GATA-3 is essential for development for thymic NK cells that express IL-7Rα and seed peripheral lymph nodes (56), while GATA-3 facilitates NK cell maturation (promoting IFN-γ production) and homing of liver-resident NK cells (94) .
Both Notch1 and GATA-3 are involved in T cell specification, although it remains unclear whether they play specific, redundant or synergistic roles in this process. Initial work by Hoflinger and colleagues using Pax5-deficient B cell progenitors cultured on Dll1expressing stroma showed that GATA-3 expression was up-regulated after 24 hours of culture in a Notch1-dependant fashion (95) . Flavell and colleagues demonstrated that Notch1 could directly regulate the expression of GATA-3 in developing Th2 cells through direct binding of RBP-Jκ to the GATA-3 promoter (73) . Together, these studies suggest that Notch1 signals might directly control GATA-3 expression in the murine T cell lineage. Interestingly, studies using human thymocyte precursors did not find GATA-3 as a Notch1 target (96, 97) . Concerning molecular mechanisms of GATA-3 action in thymocyte development, few transcriptional targets have been identified. The enhancers of the CD3δ and the TCRα, -β, -γ, and -δ genes contain GATA binding sequences (100-102) consistent with the lack of functional TCR rearrangements in GATA-3-deficient DN3 cells (90) . Using microarray analysis of WT and GATA-3-deficient DN2 cells, we found that Bcl11b expression was markedly decreased in the absence of GATA-3 (García-Ojeda, Klein Wolterink et al, unpublished results). The strong increase in Bcl11b expression during the transition from DN2 to DN3 stages suggests that GATA-3 may play a role in up-regulation of Bcl11b, which as described below, is a critical determinant of T cell commitment.
Id2
Inhibitor of DNA binding 2 (Id2) is one of four related helix-loop-helix (HLH) proteins that inhibit transcriptional activity of basic HLH E-box transcription factors, such as E2A, E2-2 and HEB (reviewed in (103) . The balance between E-box and Id proteins clearly influences cell fate decisions within the hematopoietic system: for example, Id2 or Id3 overexpression efficiently inhibits B and T cell developmental programs from hematopoietic precursors (104), whereas E2A-deficiency results in a B cell developmental arrest (105) . In contrast, Id proteins favor generation of NK cells under these conditions and Id2 is essential for BM NK cell development in vivo (106) .
The role of Id2 in the generation of thymic NK cells is not fully defined. Id2 plays an important role in NK cell lineage commitment from thymic bi-potent T/NK cell precursors is evidenced in the mouse by the fact that early thymocytes can be directed to the NK lineage by ectopic expression of Id2 and that Id2-deficiency appears to eliminate thymic NK cell precursors (107) . Nevertheless, the residual population of NK cells that has been documented in the spleens of Id2-deficient mice bears IL-7Rα (108) . As thymic NK cells express IL-7R (56), this led Boos and colleagues to propose that these few NK cells in Id2-deficient mice were the product of a thymic pathway of NK cell development that was Id2-independent (108) . While this remains possible, we have observed that thymic NK cells are strongly decreased in the absence of Id2 and that the athymic (Foxn1-deficient) nude mice 
Nfil3
Nfil3 (nuclear factor interleukin-3 regulated), also known as E4bp4 (E4-binding protein 4) is a basic leucine zipper (bZIP) transcriptional activator and was initially described for its ability to limit viral transcription and for promoting IL-3 mediated survival of pro-B cells (110) . The involvement of bZIP proteins in the control of developmental processes both in and outside the hematopoietic system suggested that Nfil3 might also serve a role in lymphoid development. Although Nfil3-deficiency did not lead to gross hematopoietic abnormalities (erythroid, myeloid and T, B and NKT cell development appeared unaffected), three independent laboratories showed that Nfil3-deficient mice almost completely lacked mature NK cells (111) (112) (113) . These observations identify Nfil3 as an essential transcription factor required for NK cell lineage development. The NK cell defects caused by Nfil3 deficiency are cell-intrinsic as they are recapitulated following transfer of Nfil-3-deficient HSC. In addition, retroviral transduction of Nfil3 into HSC promoted NK cell (111) . 
Bcl11b
Bcl11b and the related Bcl11a are Krüppel-like transcription repressors that play essential and opposing roles in lymphocyte development. Whereas Bcl11a has mainly been implicated in B cell development (114) , Bcl11b plays a major role in early T cell development (115) . Bcl11b acts as a stimulator of TCRβ gene rearrangement, necessary for αβ but not γδ T cell development, and also plays an important role in early thymocyte survival and expansion via regulation of Bcl-X L (115, 116) . Recent studies further characterized the role of Bcl11b in the stepwise differentiation of early thymocyte precursors (117, 118) . In the absence of Bcl11b, a profound developmental block at the CD44 + CD25 + DN2 stage could be documented. Bcl11b-deficient DN2 cells appeared T-lineage specified as they expressed normal levels of Gata3, Tcf7 and Ets1 (119) . In contrast, stem cell-like genes (Tal1, Sfpi1, Lyl1, Gfi1b, Erg) and genes that are normally associated with a NK cell identity (Id2, Il2rb, Ncr1 and Nfil3) were de-repressed in Bcl11b-deficient DN2 cells. These results place Bcl11b as a major regulator of T cell identity in multipotent thymocyte progenitors that acts to extinguish alternative cell fates (including the NK cell lineage).
What signals regulate Bcl11b expression at the DN2 stage? DN2 cells can be maintained in vitro using immobilized Dll4 in the presence of IL-7, SCF and Flt3L (117) and retain potentials to develop into αβ T cells, NK cells, dendritic cells and macrophages. By simply reducing IL-7 levels, these DN2-dominated cultures demonstrate brisk and robust T cell differentiation. This observation suggested that IL-7 acts as a rheostat to regulate further T cell development. Ikawa and colleagues further showed that Bcl11b expression was inversely related to IL-7 levels thereby linking this cytokine/transcription factor pair in control of T cell commitment (117) . Notch signaling has been suggested to regulate both GATA-3 and Bcl11b expression (118, 120) . Critical targets of GATA-3 (that are either activated or repressed) are not known, although Bcl11b now emerges as a potential candidate.
Integrating T/NK cell fate decisions during early thymopoiesis
The thymus is considered as the "cradle" for T cell development since this organ provides the unique microenvironment that simultaneously promotes T cell development and suppresses many residual cell fates in the developing hematopoeitic precursors that enter into it. How is it then possible that NK cells (and to a lesser extent DC, myeloid cells and B cells) develop within this "hostile" environment? One simple model would propose that these non-T cell fates would result only upon failure to successfully complete the T cell program.
Nevertheless, experimental evidence for signs of "T cell failure" (i.e. out of frame TCRβ chain VDJ rearrangements) is generally lacking in non-T cells in the thymus or outside of it.
We are therefore left with the model whereby early thymocyte progenitors may have an equally good chance of becoming a T cell or any one of the non-T cell fates. Let's examine such a model in more detail.
With the assumption that immature thymic progenitors have equal potential to develop into cells of any lineage, cell-cell interactions within the thymic microenvironment, together with the directed or stochastic expression of cytokine receptors, might provide the signals that then lead to changes in the expression of specific transcription factors (121, 122) . These transcription factors (acting alone or in concert) control gene expression and subsequent lineage specification and at the same time the repression of genes from alternative cells fates.
Ultimately, the successful commitment and differentiation to the T cell lineage will depend on the interplay of several different transcription factors (including Notch1, GATA-3, Bcl11b and others) that are expressed at early stages of T cells development. Recent data demonstrated the necessity for continued expression of some of these factors to maintain "T cell identity", suggesting that permanent suppression of other cell fates (at least for the NK cell lineage) may operate even in mature T cells (118) .
Initiation of T cell differentiation depends on Notch1 signalling. Without Notch1 signals, T cell precursors fail to become specified, and instead give rise to B cells (68) . This function of Notch1 is mediated by the conversion of RBPSuh, a repressor by default into an activator as a result of translocation of the intracellular domain of Notch to the nucleus (123, 124) . However, DN1 cells that have experienced Notch signals (for even extended periods) have not fully excluded their B cell potential (125) , indicating that there is (at least) one additional factor necessary that acts in concert with Notch1 to extinguish B cell potential as cells progress to the DN2 stage (where B cell potential is completely suppressed, (38)). As Runx3 is highly expressed in the DN1 subset and has been shown to control IL-2Rβ expression in developing NK cells (126) . A fraction of DN2 cells can apparently up-regulate IL-2Rβ expression possibly due to sustained Runx3 expression. Accordingly, these cells would become sensitive to locally produced IL-15 in the thymus. How could IL-15 signalling help specify the NK cell lineage program? Nfil3 can be induced in hematopoietic precursors following exposure to IL-15 (111) . Still, additional intrathymic signals would be necessary for commitment to the NK cell lineage as Nfil3 is also expressed by non-NK cells (including DC and myeloid cells) and can be induced upon stimulation in B cells (112, 113) . One possibility would involve Nfil3-induced Id2 expression (111) . Moreover, Nfil3 may also be involved in DN2a cells would therefore be major determinants of the T versus NK cell fate at this critical juncture. Interestingly, DN2a and DN2b cells express similar amounts of Bcl11b mRNA (38) .
While this might not necessarily translate into similar levels of Bcl11b protein in these populations, it could indicate that the promotion of the T cell fate and the suppression the NK cell fate might necessitate additional signals. However, once the T cell fate is established Bcl11b appears to be sufficient to assure this as deletion of only Bcl11b in mature, peripheral T cells results in the conversion of these cells into NK cells (ITNK; (118) ).
In line with this model in which relative expression levels of Nfil3/Bcl11b determine DN2 NK/T cell fate decisions, we found that Nfil3 was also expressed by all DN subsets (Vosshenrich et al., unpublished results) . Although Nfil3 levels are lower than in NK cells (including thymic NK cells), highest expression levels are found among the DN2 subset and decline during subsequent stages of T cell differentiation. A similar phenomenon may explain the expression of Bcl11b by a fraction of thymic NK (118) that might hint at their 'DN2 origins' and would be extinguished as these cells mature further.
In conclusion, much of the recent data appear to indicate a decisive split between T cell and thymic NK cell fate at the DN2 stage. Does this imply that all thymic NK cells transit via the DN2 intermediates? We think that this is not likely to be the case, as thymic NK cells can develop normally in absence of Notch signalling that lack ETP and DN2 cells (Ribeiro et al., unpublished). Thus, the DN2 stage probably does not represent an obligatory stage in the development of thymic NK cells. Alternative sources for DN2-independent thymic NK cells include other BM-derived multi-potent hematopoietic precursors or NKP themselves. Elevated Nfil3 expression in any of these precursors would promote their NK potential given a sufficient amount of IL-15 in the tissue microenvironment. The proportion of thymic NK cells that express Bcl11b (as a possible indictor of passage through the DN2 stage) could provide an indicator of the relative contribution of these different pathways. 
